Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site

Biochem Biophys Res Commun. 1990 Oct 30;172(2):529-36. doi: 10.1016/0006-291x(90)90705-r.

Abstract

A synthetic decapeptide, P-194, which has the sequence No. 103 to 111 of hTSH receptor structure with an additional N-terminal tyrosine, did not bind TSH nor affected its receptor binding and thyroid stimulating activity. Preincubation of P-194 with sera from thyroid patients caused a significant decrease in TBII activity in almost all 12 TBII positive sera and an increase of thyroid stimulating activity in 3 of 7 Graves' IgG studied. In addition, [125I] P-194 bound to serum IgG fraction from thyroid patients with a positive correlation with TBII (N = 35, r = 0.509, p less than 0.01). The P-194 portion may be, at least a part of, TBII binding site distinct from the TSH binding site on the TSH receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies / metabolism*
  • Binding Sites
  • Cell Membrane / metabolism
  • Humans
  • Immunoglobulins, Thyroid-Stimulating
  • Kinetics
  • Oligopeptides / chemical synthesis
  • Receptors, Thyrotropin / immunology*
  • Receptors, Thyrotropin / metabolism
  • Swine
  • Thyroid Diseases / immunology
  • Thyroid Diseases / metabolism
  • Thyroid Gland / immunology*
  • Thyroid Gland / metabolism
  • Thyrotropin / metabolism*

Substances

  • Autoantibodies
  • Immunoglobulins, Thyroid-Stimulating
  • Oligopeptides
  • Receptors, Thyrotropin
  • Thyrotropin